CS logo
small CS logo
Clinica Universidad de Navarra Madrid; Servicio de Oncología

Madrid, Spain

About Clinica Universidad de Navarra Madrid; Servicio de Oncología


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Clinica Universidad de Navarra Madrid; Servicio de Oncología


During the past decade, Clinica Universidad de Navarra Madrid; Servicio de Oncología conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Universidad de Navarra Madrid; Servicio de Oncología" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Clinica Universidad de Navarra Madrid; Servicio de Oncología


According to Clinical.Site data, the most researched conditions in "Clinica Universidad de Navarra Madrid; Servicio de Oncología" are "Solid Tumors" (3 trials), "Carcinoma, Hepatocellular" (2 trials), "Metastatic Melanoma" (2 trials), "Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers" (1 trials) and "Biliary Tract Cancer" (1 trials). Many other conditions were trialed in "Clinica Universidad de Navarra Madrid; Servicio de Oncología" in a lesser frequency.

Clinical Trials Intervention Types at Clinica Universidad de Navarra Madrid; Servicio de Oncología


Most popular intervention types in "Clinica Universidad de Navarra Madrid; Servicio de Oncología" are "Drug" (14 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (6 trials), "Gemcitabine" (2 trials), "Obinutuzumab" (2 trials), "Tocilizumab" (2 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Clinica Universidad de Navarra Madrid; Servicio de Oncología


The vast majority of trials in "Clinica Universidad de Navarra Madrid; Servicio de Oncología" are 13 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Clinica Universidad de Navarra Madrid; Servicio de Oncología


Currently, there are NaN active trials in "Clinica Universidad de Navarra Madrid; Servicio de Oncología". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Clinica Universidad de Navarra Madrid; Servicio de Oncología, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Clinica Universidad de Navarra Madrid; Servicio de Oncología, 8 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".